Navigation Links
Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
Date:3/24/2009

HAYWARD, Calif., March 24 /PRNewswire/ -- Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety and efficacy data from the first cohort of 30 patients, an independent Data Safety Monitoring Board (DSMB) has recommended that Anthera's Phase II clinical trial, known as the IMPACTS (Investigation of the Modulation of Phospholipase in Acute ChesT Syndrome) Study can continue under the current protocol based on favorable interim results.

IMPACTS is a Phase II multi-center clinical trial evaluating the safety and effectiveness of intravenous A-001 (varespladib sodium) in preventing the development of acute chest syndrome in hospitalized sickle cell disease patients. Enrolled patients are at-risk for acute chest syndrome based on the combination of pain (vaso-occlusive crisis)¿ fever¿ and elevated serum level of the enzyme (secretory phospholipase or sPLA2). Acute chest syndrome is a life-threatening complication of sickle cell disease and one of the most common causes of death in this population.

"We look forward to continuing the A-001 trial under our original protocol," said Dr. James E. Pennington, M.D., Executive Vice President and Chief Medical Officer of Anthera Pharmaceuticals, Inc. "We believe a drug that is deemed to be safe and able to suppress inflammation by inhibiting sPLA2 provides an opportunity for early intervention for patients where current treatment options are limited."

"Today's announcement marks an exciting milestone for Anthera and more importantly, the sickle cell patient population," said Paul F. Truex, President and Chief Executive Officer of Anthera Pharmaceuticals, Inc. "We are pleased with the continued progress of our varespladib clinical programs for cardiovascular and sickle cell disease where
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
2. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
3. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
4. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
5. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
6. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
7. Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
8. New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation
9. Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
10. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
11. CPR Data Debriefing by Hospital Responders Improves CPR Performance and Increases Initial Survival Rate Following Cardiac Arrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... SANTA CLARA , Kalifornien, 26. März ... neue Veranstaltung Cellworld 2015, die sich speziell ... Bioprozesstechnologien richtet, an. Die zweitägige ... bis 22. September 2015 im Hyatt Regency ... statt. In diesem Forum werden führende ...
(Date:3/26/2015)... de 2015 A Finesse Solutions anunciou a ... para os inovadores, visionários e executivos seniores em bioprocessamento. ... convite, será realizada no Hyatt Regency em ... de setembro de 2015. Será um fórum de líderes ... fabricação de produtos biofarmacêuticos de uso único e ouvir ...
(Date:3/26/2015)... , March 26, 2015 Finesse Solutions ... designed for innovators, visionaries and senior executives in bio-processing. ... will be held at the Hyatt Regency in ... 2015.  It will be a forum for life science ... and to hear about both disruptive technologies and best ...
Breaking Medicine Technology:Finesse Solutions kündigt Cellworld 2015 an 2Finesse Solutions anuncia Cellworld 2015 2Finesse Solutions Announces Cellworld 2015 2
(Date:3/26/2015)... March 26, 2015 Doctors Scott Sullivan ... Restorative Breast Surgery (CRBS) and the St. ... pleased to announce that board certified Surgical Oncologist Dr. ... of surgeons. Ordoyne joins fellow breast surgical oncologist Alan ... including Frank DellaCroce, M.D., FACS; Scott Sullivan, M.D., FACS; ...
(Date:3/26/2015)... NJ (PRWEB) March 26, 2015 ... statistical consulting firm, announced the release of BathroomMap® ... experts to increase access to public restrooms for travelers, ... in bathroom apps, BathroomMap does not facilitate a paid, ... algorithm to identify and rate local establishments that have ...
(Date:3/26/2015)... 2015 U.S. medical real estate ... 2014, according to an exclusive new report now ... real estate (HRE) data firm also announced that ... new Gold-Level Partners: Harrison Street Real Estate Capital ... transactions still going strong, yields compressed, prices per ...
(Date:3/26/2015)... Philadelphia, PA (PRWEB) March 26, 2015 ... to identifying brain aneurysms and preventing often fatal ... non-profit organization dedicated to raising awareness of brain ... , The issue has captured national attention with ... Colagrossi , 49, who died last Friday after ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... the Patients’ Access to Treatments Act (PATA) that ... week by Reps. David B. McKinley (R-WV) and ... limit cost-sharing requirements for medications placed in a ... by reducing patients’ out-of-pocket expenses. , This legislation ...
Breaking Medicine News(10 mins):Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2
... Nov. 24 The holiday season can be a time ... many people, especially those recovering from an eating disorder, it,s ... anxiety about an uncertain future. Family gatherings with a loved ... and sometimes awkward. , "In my practice, I ...
... , SAN FRANCISCO, Nov. 24 ... and services provider, announced today that it has licensed ... of Michigan for integration into Quantros, suite of safety ... software within the SRM product family will enable automated ...
... N.Y., Nov. 24 IPRO has achieved its ... standard focused on fulfilling customer requirements, enhancing customer ... to ISO 9001:2008 by SGS International Certification Services ... a rigorous external audit encompassing operations at its ...
... needed when taking sedatives, antidepressants, benzodiazepines, review finds ... who take antidepressants, sedatives and other psychotropic medications ... new review shows. , Canadian researchers analyzed 22 ... participants older than 60. The studies evaluated nine ...
... Nov. 24 Governor Edward G. Rendell today announced ... vaccinated during the weekend at public health clinics held ... , "With the federal government unable to provide ... vaccine, distribution has been challenging," said Governor Rendell. "Overall, ...
... , , PITTSBURGH, Nov. 24 While ... celebrate, this time of the year can be difficult for ... death, every day is difficult for children and families. The ... grieving. , The Highmark Caring Place, A Center for Grieving ...
Cached Medicine News:Health News:When Holiday Meals Aren't a Gift 2Health News:When Holiday Meals Aren't a Gift 3Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 3Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2
... 2 60-ms bursts of 50 Hz separated by .75 ... Tetanus: 50 Hz (50 pulses/s) or 100 Hz (100 ... Output Current: Adjustable from 0-70 mA , Stimulus ... Battery LED (green) indicates that the units on; it ...
Anesthesia Associates Nerve Stimulator Model AA 1050...
... newest peripheral nerve stimulator from B. Braun Medical. ... providing advanced digital technology. , ,Your ability ... allows the localization of practically all mixed nerves ... ,An additional optional component for the HNS11 is ...
... original MS-III design the new ... keypad and battery ... MS-IV peripheral nerve stimulator can ... in operating room, post anesthesia ...
Medicine Products: